Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study.
Rozenkiewicz D, Esteve-Palau E, Arenas-Miras M, Grau S, Duran X, Sorlí L, Montero MM, Horcajada JP. Rozenkiewicz D, et al. Among authors: arenas miras m. Antibiotics (Basel). 2021 May 15;10(5):585. doi: 10.3390/antibiotics10050585. Antibiotics (Basel). 2021. PMID: 34063338 Free PMC article.
Clinical experience of TB in patients treated with anti-TNF-α.
Arenas-Miras M, Sánchez-Martínez F, Jové-Caballé N, Villar-García J, López-Montesinos I, Grau S, Carballo N, Knobel-Freud H, Horcajada JP. Arenas-Miras M, et al. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):866-868. doi: 10.5588/ijtld.21.0166. Int J Tuberc Lung Dis. 2021. PMID: 34615586 No abstract available.
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.
Sendra E, López Montesinos I, Rodriguez-Alarcón A, Du J, Siverio-Parés A, Arenas-Miras M, Cañas-Ruano E, Prim N, Durán-Jordà X, Blasco-Hernando F, García-Alzorriz E, Cots F, Ferrández O, Gómez-Zorrilla S. Sendra E, et al. Among authors: arenas miras m. Antibiotics (Basel). 2022 Oct 29;11(11):1511. doi: 10.3390/antibiotics11111511. Antibiotics (Basel). 2022. PMID: 36358167 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33714660
Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results.
Sánchez-Martínez F, Arenas-Miras M, Jové-Caballé N, Knobel-Freud H; COVID-19 Infectious Disease Team Hospital del Mar. Sánchez-Martínez F, et al. Among authors: arenas miras m. Arch Bronconeumol. 2021 Apr;57:58-59. doi: 10.1016/j.arbres.2021.02.003. Epub 2021 Feb 13. Arch Bronconeumol. 2021. PMID: 34629655 Free PMC article. No abstract available.
Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).
Horcajada JP, Aldonza R, Real M, Castañeda-Espinosa S, Sendra E, Gomez-Junyent J, López-Montesinos I, Gómez-Zorrilla S, Briansó S, Duran-Taberna M, Fernández A, Tarragó C, Auguet-Quintillá T; COVID-MAR Research group; COVID-HJ23 group. Horcajada JP, et al. Pneumonia (Nathan). 2024 Feb 25;16(1):3. doi: 10.1186/s41479-023-00124-6. Pneumonia (Nathan). 2024. PMID: 38402214 Free PMC article.
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality.
de Pablo-Miró M, Pujol-Ruiz S, Iftimie S, Arenas-Miras MDM, López-Montesinos I, Duran-Jordà X, Anglès A, Grau S, Horcajada JP. de Pablo-Miró M, et al. Among authors: arenas miras mdm. Antibiotics (Basel). 2021 Oct 24;10(11):1296. doi: 10.3390/antibiotics10111296. Antibiotics (Basel). 2021. PMID: 34827234 Free PMC article.
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J; REIPI-SEIMC COVID-19 group and COVID@HULP groups. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2021 Jun;21(6):783-792. doi: 10.1016/S1473-3099(21)00019-0. Epub 2021 Feb 23. Lancet Infect Dis. 2021. PMID: 33636145 Free PMC article.
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.
Hidalgo-Tenorio C, Vinuesa D, Plata A, Martin Dávila P, Iftimie S, Sequera S, Loeches B, Lopez-Cortés LE, Fariñas MC, Fernández-Roldan C, Javier-Martinez R, Muñoz P, Arenas-Miras MDM, Martínez-Marcos FJ, Miró JM, Herrero C, Bereciartua E, De Jesus SE, Pasquau J. Hidalgo-Tenorio C, et al. Among authors: arenas miras mdm. Ann Clin Microbiol Antimicrob. 2019 Oct 19;18(1):30. doi: 10.1186/s12941-019-0329-6. Ann Clin Microbiol Antimicrob. 2019. PMID: 31629409 Free PMC article.
16 results